Delivery Order SPE2DR25D2216-SPE2DR26F7UC0
Award Date 11/25/25
Potential Completion Date 11/26/25
Potential Value $29K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 11, 2025, for the supply of Xifaxan 550 mg tablets (60-count units) with a ceiling value of $5,028.93. This firm fixed-price, non-set-aside contract is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania, and carries an ultimate completion date of August 12, 2025. The delivery order represents a routine pharmaceutical procurement supporting federal medical...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Xifaxan 550 mg tablets (60-count) valued at $17,574.14 under a firm fixed-price contract. This award, issued on August 26, 2025, represents a non-set-aside competitive procurement and is classified as a child contract, indicating it derives from a larger indefinite delivery vehicle. The delivery order has an ultimate completion date of August 27,...
- The Defense Logistics Agency awarded a delivery order valued at $46,987.66 to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count packages) on November 28, 2025, with completion scheduled for December 1, 2025. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,279.67 on January 28, 2026, for the supply of Xifaxan 550 mg tablets (60-count packages). The contract is non-competitively set aside and features firm fixed pricing with an ultimate completion date of January 29, 2026. The Defense Logistics Agency, which falls under the Department of Defense, is the funding federal agency. This delivery order...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,869.31 for 60 tablets of Xifaxan 550 mg on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The pharmaceutical product will be supplied to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Xifaxan 550 mg tablets (60-count units) with a ceiling value of $6,251.05. This firm fixed-price delivery order, which is due for completion by December 4, 2025, was competitively awarded with no set-aside designation and will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $16,612.59 to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count units). This firm fixed-price delivery order, awarded on December 2, 2025, with an ultimate completion date of December 3, 2025, represents a non-competitive set-aside award. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count units) under a firm fixed-price contract with a ceiling value of $2,603.49. This non-set-aside delivery order was awarded on November 20, 2025, with an ultimate completion date of November 21, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and distribution operations....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,167.66 on November 10, 2025, for the supply of Xifaxan 550 mg tablets (60-count packages). This is a firm fixed price, non-set-aside contract with performance through November 12, 2025, and fulfillment at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $41,547.36 to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count units) on October 27, 2025, with completion targeted for October 28, 2025. This firm fixed-price, non-set-aside contract represents a single delivery under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The performance...